Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective
Leprosy (Hansen’s disease) caused by Mycobacterium lepra is a debilitating tropical disease having maximal stigma till date. Efforts have been made for many decades to keep disease incidence under control. In 2019, 202,185 new cases of leprosy were reported around the world, with 14,981 (7.4%) of th...
Gespeichert in:
Veröffentlicht in: | Journal of young pharmacists 2022-07, Vol.14 (3), p.266-267 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Leprosy (Hansen’s disease) caused by Mycobacterium lepra is a debilitating tropical disease having maximal stigma till date. Efforts have been made for many decades to keep disease incidence under control. In 2019, 202,185 new cases of leprosy were reported around the world, with 14,981 (7.4%) of those found in children under the age of 15.1-3 Globally in 2020, 1, 28,405 new leprosy patients were diagnosed. New paediatric cases were 8661 diagnosed with leprosy and 7216 patients with grade 2 disability by WHO region. Read more. . . |
---|---|
ISSN: | 0975-1483 0975-1505 |
DOI: | 10.5530/jyp.2022.14.53 |